EMA welcomes political agreement on Critical Medicines Act

The European Medicines Agency (EMA) has  welcomed the provisional agreement reached by the European Parliament and the Council of the European Union on the proposed Critical Medicines Act (CMA), which represents an important step in strengthening the resilience, security and sustainability of the European Union’s supply of critical medicines.

“At a time of increasing global disruptions, resilient and secure supply chains for critical medicines are essential to protect public health across the EU,” said Emer Cooke, the EMA’s executive director, adding: “Today’s provisional agreement on the Critical Medicines Act marks a significant milestone towards strengthening Europe’s capacity to improve the availability, supply and production of critical medicines.”